BrainStorm Cell Therapeutics Loses Co-CEO Lindborg, Names Dagher as New Medical Chief
By Ben Glickman BrainStorm Cell Therapeutics named a new medical chief and said Co-Chief Executive Stacy Lindborg would step down ahead of a long-awaited…
By Ben Glickman BrainStorm Cell Therapeutics named a new medical chief and said Co-Chief Executive Stacy Lindborg would step down ahead of a long-awaited…
This year’s conference will celebrate the 25th anniversary of the founding of the KDA. As always, the conference will provide a venue for patients, families,…
Raise awareness & raise funds for spinal CSF leak education and research via the Spinal CSF Leak Foundation! #becauseyourduramaters
AMP ALS, the latest public-private partnership in the FNIH’s growing AMP portfolio, will centralize and build the largest data source for ALS research. This …
The Accelerating Medicines Partnership® (AMP®) Amyotrophic Lateral Sclerosis (AMP ALS) is accelerating therapeutic and biomarker development for familial and sporadic ALS by addressing the challenges…
May 21, 2024 — The National Organization for Rare Disorders (NORD), in partnership with the Tyler James Abizeid Foundation and the MMIHS Foundation, announces
Nature Reviews Neurology – In this Perspective, the authors propose a new classification system for amyotrophic lateral sclerosis and related neurodegenerative disorders that recognizes, in…
Plan ahead. Actively listen. And discuss how to move forward.
Nora Kenworthy has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that…
The Elon Musk-backed startup has proposed solutions for a thread pullout problem experienced by its first participant, Noland Arbaugh.
Guidance for developing drugs to treat early Alzheimer@s disease should focus on factors such as cognitive changes and brain atrophy, according to comments submitted to…